Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T14879 | CB 300919 | Others | Others |
CB 300919 is a quinazoline-based antitumor agent with high activity in the CH1 human ovarian tumor xenograft and has continuous exposure (96 h) growth inhibition (IC50: 2 nM). |